Optimal therapy of malignant pleural effusions: Report of a randomized trial of bleomycin, tetracycline, and talc and a meta-analysis

International Journal of Oncology

Volumn 8, Issue 1, 1996, Pages 183-190

  Lynch Jr , Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

bleomycin; chest tube sclerosis; malignant pleural effusion; meta analysis; randomized allocation; talc; tetracycline

Indexed keywords

BLEOMYCIN; LIDOCAINE; TALC; TETRACYCLINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAPLEURAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PHASE 3 CLINICAL TRIAL; PLEURA EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROSIS;

EID: 0030060102     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Boring C, Squires T, Tong T: Cancer Statistics. CA 42: 19-38, 1992.
2. Sahn S: The pathophysiology of pleural effusions. Annu Rev Med 41: 7-13, 1990.